MHRA: Europe-wide withdrawal of lumiracoxib
Following the suspension of lumiracoxib licences in the UK (19 November 2007), and similar action in some other countries
more ...
Sunday, 16 December 2007
Archive
-
▼
2007
(105)
-
▼
December
(18)
- RCoA: MMC England - letter to trainees
- RCoA: Results of Election to Council
- MHRA: MDA/2007/100 - Volumetric infusion pump
- MHRA: MDA/2007/099 - Blood/solution warming units
- MHRA: Position on the sale and supply of co-proxamol
- MHRA: Europe-wide withdrawal of lumiracoxib
- MHRA: MDA/2007/097 - Infusion pump software for ta...
- IASP: Ethics of Opioid Analgesia for Chronic Nonca...
- IASP: Award for Excellence in Pain Research and M...
- PMETB: PMETB CESR/CEGPR Fees Consultation
- RCoA: Supervision of Anaesthesia Practitioners (AP...
- CEMACH: Saving Mothers’ Lives
- MHRA: Ceftriaxone - incompatibility with calcium-c...
- MHRA: MDA/2007/094 - Robertshaw endobronchial tubes
- MHRA: MDA/2007/090 - Anaesthetic Gas Scavenging Sy...
- MHRA: Intravenous (IV) infusion lines - all brands
- BPS: The assessment of pain in older people
- SASM: Summary report 2007
-
▼
December
(18)